US Broker Ratings

Vaxcyte, Inc. (PCVX) Stock Analysis: Unlocking a Potential 234.91% Upside in Biotechnology

Vaxcyte, Inc. (NASDAQ: PCVX), a burgeoning player in the biotechnology sector, has captured the attention of investors with its ambitious pipeline of vaccine candidates aimed at..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 51.8% Potential Upside in the Biotech Sector

Nuvalent, Inc. (NASDAQ: NUVL), a rising star in the biotechnology sector, is capturing the attention of investors with its innovative approach to cancer treatment. Headquartered in..

Humana Inc. (HUM) Stock Analysis: Exploring an 18% Potential Upside Amid Healthcare Sector Dynamics

For investors eyeing the healthcare sector, Humana Inc. (NYSE: HUM) presents a compelling case with its diversified offerings and solid market position. As a major player..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring Growth Potential and Analyst Ratings

HCA Healthcare, Inc. (NYSE: HCA) stands as a significant player in the healthcare sector, particularly within the medical care facilities industry in the United States. With..

Merit Medical Systems, Inc. (MMSI): Investor Outlook on Growth Potential and Analyst Consensus

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 32.68% Potential Upside Amidst Robust Revenue Growth

Investors looking for opportunities in the healthcare sector may want to turn their attention to Intuitive Surgical, Inc. (NASDAQ: ISRG), a leading innovator in the medical..

ICON plc (ICLR) Investor Outlook: Navigating Volatility with a 23.95% Potential Upside

Investors looking for opportunities in the healthcare sector may find ICON plc (NASDAQ: ICLR) an intriguing candidate. The company, headquartered in Dublin, Ireland, is a global..

Masimo Corporation (MASI) Stock Analysis: Exploring a 33.57% Potential Upside for Investors

Masimo Corporation (MASI), a prominent player in the healthcare sector, continues to capture investor attention with its innovative contributions to the medical devices industry. Headquartered in..

Biogen Inc. (BIIB) Stock Analysis: Unpacking a 19% Upside Potential Amidst Healthcare Innovation

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, continues to intrigue investors with its innovative approach to neurological and neurodegenerative disease treatments. With a..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Healthcare Leader Faces Mixed Signals Amidst Market Volatility

Investors with a keen eye on the healthcare sector might find Bausch + Lomb Corporation (NYSE: BLCO) intriguing, particularly given its longstanding reputation in the eye..

Bruker Corporation (BRKR) Stock Analysis: Evaluating a 40.87% Potential Upside in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, particularly within the medical devices industry, is capturing the attention of investors with its promising..

Madrigal Pharmaceuticals (MDGL): Growth Potential in Biotech with a 9.53% Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a key player in the biotechnology sector, is garnering significant attention from investors due to its promising pipeline in the healthcare..

ResMed Inc. (RMD) Stock Analysis: A Healthcare Giant with 7.36% Upside Potential

ResMed Inc. (RMD) stands as a formidable entity within the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization of $40..

Royalty Pharma plc (RPRX) Stock Analysis: Unpacking a 24% Potential Upside in the Biotech Arena

Royalty Pharma plc (NASDAQ: RPRX) is carving out a distinct niche in the healthcare sector as a prominent player in the biotechnology industry. Specializing in the..

RadNet, Inc. (RDNT): Investor Outlook on a Promising Healthcare Innovator with 3.72% Upside Potential

RadNet, Inc. (NASDAQ: RDNT) is making waves in the healthcare sector, specifically within the diagnostics and research industry. With a market cap of $5.88 billion, RadNet..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A Biotech Powerhouse with 100% Revenue Growth and a Promising 13.42% Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is a formidable player in the biotechnology sector, focusing primarily on RNA-targeted medicines. With a market capitalization of $9.72 billion, Ionis..

Alkermes plc (ALKS) Stock Analysis: Unlocking a 49.65% Potential Upside in Biopharmaceuticals

Alkermes plc (NASDAQ: ALKS) is capturing investor attention with its impressive potential upside of nearly 50%, positioning itself as a compelling contender in the healthcare sector...

Stevanato Group S.p.A. (STVN) Stock Analysis: Solid Buy Ratings Propel a Promising 6.87% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN) has emerged as a noteworthy player in the healthcare sector, specifically within the Medical Instruments & Supplies industry. Headquartered in Piombino..

Revolution Medicines, Inc. (RVMD) Investor Outlook: Analysts Predict a Staggering 73% Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) is making waves in the biotechnology sector with a remarkable potential upside that has captured the attention of investors. With a..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Understanding the 33% Upside Potential in the Biotech Sector

Roivant Sciences Ltd. (ROIV), a prominent player in the biotechnology industry, is making waves in the healthcare sector with its innovative approach to drug development. Based..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds